2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$66.08+$0.02 (+0.03%)
Price as of Sep 11, 2026 7:47 PM EDT- $5.5BMarket Cap
- 8.14%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$66.08+$0.02 (+0.03%)
Earnings Score
Valuation | PTCT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 15 |
Momentum Score
Valuation | PTCT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -1.41% | ||
12-Month Momentum | 19.16% | ||
3-Month Risk Adjusted Momentum | -7.56% | ||
12-Month Risk Adjusted Momentum | 48.95% |
True Yield
Valuation | PTCT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.32% |
Financial Health Score
Valuation | PTCT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |